CITADEL ADVISORS LLC 13D and 13G filings for Genocea Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 06:19 am Sale | 2021-12-31 | 13G | Genocea Biosciences, Inc. GNCA | CITADEL ADVISORS LLC | 3,535,358 6.200% | -51,718 (-1.44%) | Filing |
| 2021-02-16 4:30 pm Purchase | 2020-12-31 | 13G | Genocea Biosciences, Inc. GNCA | CITADEL ADVISORS LLC | 3,587,076 6.700% | 154,690 (+4.51%) | Filing |
| 2020-07-31 4:31 pm Purchase | 2020-07-22 | 13G | Genocea Biosciences, Inc. GNCA | CITADEL ADVISORS LLC | 3,432,386 6.500% | 3,432,386 (New Position) | Filing |